Manual analysis is the bottleneck.
Competitive intelligence teams spend around 70% of their time collecting, monitoring and synthesising public information, leaving barely 29% for the work that actually moves decisions.
And the market is getting harder. The drug development pipeline has more than doubled in five years, while roughly two-thirds of competitive intelligence leaders expect flat budgets and headcount. More to watch, the same people to watch it.
That's why RxClarity exists.
We spent years working with big data in healthcare and commercial intelligence as the people who used many CI tools. We know exactly how time-consuming and costly the groundwork is.
So we built the team you couldn't afford to hire. You create your own commercial intelligence agents — specialist agents that watch your markets continuously, collecting, monitoring and synthesising around the clock. They take on the groundwork, so your team's time goes where it counts: strategy, judgment, the next decision.
And because inaccuracy is the single most common problem with AI — hitting around a third of companies — every output is checked and traced back to its source. So what lands on your desk is something you can act on and stand behind.
Faster time to insight. Better decisions.
Zaharan Sofi
Spent over a decade in pharma and healthcare as the person these tools are sold to, working in data analytics within healthcare consulting and as a buyer and super-user of the leading competitive intelligence platforms.
Ben Riazy
Two decades building and scaling software products. Founder and leader of several VC-backed startups including Infinity Health.
Chris Crabtree
15+ years across pharmaceutical and life sciences, with broad expertise in commercial, portfolio strategy, and R&D.